FrancophonIA/ELRC3.0 huggingface dataset:
English: EU/1/01/185/032 4 Pack Blister
Slovenian: EU/1/01/185/032 pakiranje po 4
English: Aranesp 130 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 2.46 mg of sodium in 0.65 mL.
Slovenian: Aranesp 130 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 2,46 mg natrija v 0,65 ml.
English: INFORMATION IN BRAILLE Aranesp 60 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 60 brizga
English: Aranesp 25 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Slovenian: Aranesp 25 mikrogramov raztopina za injiciranje v viali Ena viala vsebuje 3,79 mg natrija.
English: Instructions for injecting with the Aranesp pre-filled syringe This section contains information on how to give yourself an injection of Aranesp.
Slovenian: To poglavje obsega informacije o tem, kako si sami injicirate zdravilo Aranesp.
English: If the rise in haemoglobin is greater than 2 g/dL (1.25 mmol/L) in four weeks reduce the dose by approximately 25%.
Slovenian: Če se hemoglobin v štirih tednih zviša za več kot 20 g/l (1,25 mmol/l), zmanjšajte odmerek za približno 25 %.
English: INFORMATION IN BRAILLE Aranesp 30 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 30 brizga
English: INFORMATION IN BRAILLE Aranesp 500 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 500 brizga
English: Aranesp 130 micrograms solution for injection pre-filled pen EU/1/01/185/072 - 1 pack
Slovenian: Aranesp 130 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/072 - pakiranje po 1
English: INFORMATION IN BRAILLE Aranesp 15 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 15 brizga
English: INFORMATION IN BRAILLE Aranesp 130 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 130 peresnik
English: INFORMATION IN BRAILLE Aranesp 50 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 50 brizga
English: Aranesp 15 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 15 micrograms of darbepoetin alfa in 0.375 mL (40 mcg/mL).
Slovenian: Aranesp 15 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 15 mikrogramov darbepoetina alfa v 0,375 ml (40 µg/ml).
English: INFORMATION IN BRAILLE Aranesp 300 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 300 brizga
English: INFORMATION IN BRAILLE Aranesp 40 pen
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 40 brizga
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 60 micrograms darbepoetin alfa.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 1-ml viala vsebuje 60 mikrogramov darbepoetina alfa.
English: INFORMATION IN BRAILLE Aranesp 15 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 15 peresnik
English: INFORMATION IN BRAILLE Aranesp 500 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 500 peresnik
English: NAME OF THE MEDICINAL PRODUCT Aranesp 200 micrograms solution for injection in vial Darbepoetin alfa
Slovenian: Aranesp 200 mikrogramov raztopina za injiciranje v viali darbepoetin alfa
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 40 micrograms darbepoetin alfa.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 1-ml viala vsebuje 40 mikrogramov darbepoetina alfa.
English: Aranesp 300 micrograms solution for injection pre-filled pen EU/1/01/185/055 - 1 pack
Slovenian: Aranesp 300 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/055 - pakiranje po 1
English: Aranesp is supplied ready for use in a pre-filled pen.
Slovenian: Zdravilo Aranesp je pripravljeno za uporabo v napolnjenem injekcijskem peresniku.
English: Do not touch the injection site before injecting Choose a different site each time you give yourself an injection.
Slovenian: Vsakič, ko si injicirate zdravilo, izberite drugo mesto.
English: Aranesp 30 micrograms solution for injection pre-filled pen EU/1/01/185/048 - 1 pack
Slovenian: Aranesp 30 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/048 - pakiranje po 1
English: INFORMATION IN BRAILLE Aranesp 10 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 10 brizga
English: INFORMATION IN BRAILLE Aranesp 80 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 80 peresnik
English: When your syringe has been removed from the refrigerator and left at room temperature for approximately 30 minutes before injection it must either be used within 7 days or disposed of.
Slovenian: Ko vialo vzamete iz hladilnika in jo pustite na sobni temperaturi približno 30 minut pred injiciranjem, jo morate uporabiti v 7 dneh, sicer jo morate zavreči.
English: Aranesp 500 micrograms solution for injection pre-filled pen EU/1/01/185/056 - 1 pack
Slovenian: Aranesp 500 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/056 - pakiranje po 1
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING VIAL CARTON
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA VIALO
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 300 micrograms darbepoetin alfa.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 1-ml viala vsebuje 300 mikrogramov darbepoetina alfa.
English: EU/1/01/185/014 4 Pack Blister
Slovenian: EU/1/01/185/014 pakiranje po 4
English: Aranesp 15 micrograms solution for injection pre-filled pen EU/1/01/185/046 - 1 pack
Slovenian: Aranesp 15 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/046 - pakiranje po 1
English: Do not remove the grey cap from the pre-filled pen until you are ready to inject.
Slovenian: Ne odstranjujte sivega pokrovčka z napolnjenega injekcijskega peresnika, dokler niste pripravljeni za injiciranje.
English: Aranesp 40 micrograms solution for injection pre-filled pen EU/1/01/185/049 - 1 pack
Slovenian: Aranesp 40 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/049 - pakiranje po 1
English: Aranesp 80 micrograms solution for injection pre-filled pen EU/1/01/185/052 - 1 pack
Slovenian: Aranesp 80 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/052 - pakiranje po 1
English: Aranesp 40 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 40 micrograms of darbepoetin alfa in 0.4 mL (100 mcg/mL).
Slovenian: Aranesp 40 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 40 mikrogramov darbepoetina alfa v 0,4 ml (100 µg/ml).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 200 micrograms darbepoetin alfa.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 1-ml viala vsebuje 200 mikrogramov darbepoetina alfa.
English: Aranesp 150 micrograms solution for injection pre-filled pen EU/1/01/185/054 - 1 pack
Slovenian: Aranesp 150 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/054 - pakiranje po 1
English: MedDRA system organ class
Slovenian: Organski sistem po MedDRA Pogostnost
English: INFORMATION IN BRAILLE Aranesp 20 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 20 peresnik
English: Aranesp 30 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 30 micrograms of darbepoetin alfa in 0.3 mL (100 mcg/mL).
Slovenian: Aranesp 30 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 30 mikrogramov darbepoetina alfa v 0,3 ml (100 µg/ml).
English: 1 single use pre-filled syringe.
Slovenian: 1 napolnjena injekcijska brizga za enkratno uporabo.
English: EU/1/01/185/059 - 4 pack
Slovenian: EU/1/01/185/059 - pakiranje po 4
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.375 mL pre-filled syringe contains 15 micrograms darbepoetin alfa (40 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 0,375-ml napolnjena injekcijska brizga vsebuje 15 mikrogramov darbepoetina alfa (40 mikrogramov/ml).
English: Aranesp 100 micrograms solution for injection pre-filled pen EU/1/01/185/053 - 1 pack
Slovenian: Aranesp 100 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/053 - pakiranje po 1
English: Cases of severe hypertension, including hypertensive crisis, hypertensive encephalopathy, and seizures, have been observed in CRF patients treated with Aranesp.
Slovenian: Pri bolnikih s kronično odpovedjo ledvic, ki so dobivali zdravilo Aranesp, so zabeležili primere hude hipertenzije, vključno s hipertenzivno krizo, hipertenzivno encefalopatijo in konvulzijami.
English: Aranesp 80 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 80 micrograms of darbepoetin alfa in 0.4 mL (200 mcg/mL).
Slovenian: Aranesp 80 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 80 mikrogramov darbepoetina alfa v 0,4 ml (200 µg/ml).
English: Do not remove the grey cap from the pre-filled pen yet.
Slovenian: Ne odstranite še sivega pokrovčka z napolnjenega injekcijskega peresnika.
English: NAME OF THE MEDICINAL PRODUCT Aranesp 40 micrograms solution for injection in vial Darbepoetin alfa
Slovenian: Aranesp 40 mikrogramov raztopina za injiciranje v viali darbepoetin alfa
English: d Oedema: includes PT Oedema Peripheral, Oedema, Generalised Oedema, Oedema due to Cardiac Disease, Face oedema e Injection site pain adverse reaction includes PT injection site pain, administration site pain, catheter site pain, infusion site pain and vessel puncture site pain.
Slovenian: e Neželeni učinek bolečina na mestu injiciranja vključuje naslednje PT: bolečina na mestu injiciranja, bolečina na mestu aplikacije, bolečina na mestu katetra, bolečina na mestu infuzije in bolečina na žilnem vbodnem mestu.
English: EU/1/01/185/066 - 4 pack
Slovenian: EU/1/01/185/066 - pakiranje po 4
English: • increased risk of death when administered to target a haemoglobin of 12 g/dL (7.5 mmol/L) in patients with active malignant disease receiving neither chemotherapy nor radiation therapy.
Slovenian: • povečala tveganje smrti pri bolnikih z aktivno maligno boleznijo, ki niso dobivali ne kemoterapije ne obsevanja, če je bila ciljna vrednost hemoglobina 120 g/l (7,5 mmol/l).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL vial contains 100 micrograms darbepoetin alfa.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 1-ml viala vsebuje 100 mikrogramov darbepoetina alfa.
English: EU/1/01/185/022 4 Pack Blister
Slovenian: EU/1/01/185/022 pakiranje po 4
English: • Rash and/or redness of the skin
Slovenian: • izpuščaj, pordelost kože ali oboje
English: Aranesp 20 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 20 micrograms of darbepoetin alfa in 0.5 mL (40 mcg/mL).
Slovenian: Aranesp 20 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 20 mikrogramov darbepoetina alfa v 0,5 ml (40 µg/ml).
English: EU/1/01/185/107 4 pack
Slovenian: EU/1/01/185/107 - pakiranje po 4
English: Aranesp 60 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 60 micrograms of darbepoetin alfa in 0.3 mL (200 mcg/mL).
Slovenian: Aranesp 60 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 60 mikrogramov darbepoetina alfa v 0,3 ml (200 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 300 micrograms solution for injection in vial Darbepoetin alfa
Slovenian: Aranesp 300 mikrogramov raztopina za injiciranje v viali darbepoetin alfa
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.4 mL pre-filled syringe contains 40 micrograms darbepoetin alfa (100 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN En 0,4-ml napolnjen injekcijski peresnik vsebuje 40 mikrogramov darbepoetina alfa (100 mikrogramov/ml).
English: EU/1/01/185/073 - 4 pack
Slovenian: EU/1/01/185/073 - pakiranje po 4
English: Aranesp 200 micrograms solution for injection in vial 1 mL solution for injection (200 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Slovenian: Aranesp 200 mikrogramov raztopina za injiciranje v viali 1 ml raztopine za injiciranje (200 µg/ml darbepoetina alfa) v viali iz stekla tipa 1 z elastomernim zamaškom, plastificirani s fluoropolimerom, in z aluminijasto zaporo in snemno zaporko proti prahu.
English: Aranesp 200 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Slovenian: Aranesp 200 mikrogramov raztopina za injiciranje v viali Ena viala vsebuje 3,79 mg natrija.
English: INFORMATION IN BRAILLE Aranesp 300 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 300 peresnik
English: Aranesp 150 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 150 micrograms of darbepoetin alfa in 0.3 mL (500 mcg/mL).
Slovenian: Aranesp 150 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 150 mikrogramov darbepoetina alfa v 0,3 ml (500 µg/ml).
English: Aranesp 130 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 130 micrograms of darbepoetin alfa in 0.65 mL (200 mcg/mL).
Slovenian: Aranesp 130 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 130 mikrogramov darbepoetina alfa v 0,65 ml (200 µg/ml).
English: NAME OF THE MEDICINAL PRODUCT Aranesp 100 micrograms solution for injection in vial Darbepoetin alfa
Slovenian: Aranesp 100 mikrogramov raztopina za injiciranje v viali darbepoetin alfa
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.3 mL pre-filled syringe contains 30 micrograms darbepoetin alfa (100 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN En 0,3-ml napolnjen injekcijski peresnik vsebuje 30 mikrogramov darbepoetina alfa (100 mikrogramov/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/071
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/071
English: EU/1/01/185/109 4 pack
Slovenian: EU/1/01/185/109 - pakiranje po 4
English: NAME OF THE MEDICINAL PRODUCT Aranesp 60 micrograms solution for injection in vial Darbepoetin alfa
Slovenian: Aranesp 60 mikrogramov raztopina za injiciranje v viali darbepoetin alfa
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.4 mL pre-filled syringe contains 10 micrograms darbepoetin alfa (25 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena 0,4-ml napolnjena injekcijska brizga vsebuje 10 mikrogramov darbepoetina alfa (25 mikrogramov/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/037
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/037
English: EU/1/01/185/058 - 4 pack
Slovenian: EU/1/01/185/058 - pakiranje po 4
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/044
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/044
English: Injecting Aranesp yourself
Slovenian: Samoinjiciranje zdravila Aranesp
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/040
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/040
English: In a randomised, double-blind, placebo-controlled study (TREAT) of 4,038 CRF patients not on dialysis with type 2 diabetes and haemoglobin levels ≤ 11 g/dL, patients received either treatment with darbepoetin alfa to target haemoglobin levels of 13 g/dL or placebo (with darbepoetin alfa rescue at haemoglobin less than 9 g/dL).
Slovenian: Randomizirana, dvojno slepa, s placebom kontrolirana študija (TREAT) je zajela 4.038 bolnikov s kronično odpovedjo ledvic, ki se niso zdravili z dializo, so imeli sladkorno bolezen tipa 2 in koncentracijo hemoglobina ≤ 110 g/l.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 1 mL pre-filled syringe contains 500 micrograms darbepoetin alfa (500 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN En 1-ml napolnjen injekcijski peresnik vsebuje 500 mikrogramov darbepoetina alfa (500 mikrogramov/ml).
English: Aranesp 150 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.14 mg of sodium in 0.3 mL.
Slovenian: Aranesp 150 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1,14 mg natrija v 0,3 ml.
English: You must stop breast-feeding if you use Aranesp.
Slovenian: Če uporabljate zdravilo Aranesp, morate nehati dojiti.
English: Aranesp 100 micrograms solution for injection in vial 1 mL solution for injection (100 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Slovenian: Aranesp 100 mikrogramov raztopina za injiciranje v viali 1 ml raztopine za injiciranje (100 µg/ml darbepoetina alfa) v viali iz stekla tipa 1 z elastomernim zamaškom, plastificirani s fluoropolimerom, in z aluminijasto zaporo in snemno zaporko proti prahu.
English: Aranesp 130 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 130 micrograms of darbepoetin alfa in 0.65 mL (200 mcg/mL).
Slovenian: Aranesp 130 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku En napolnjeni injekcijski peresnik vsebuje 130 mikrogramov darbepoetina alfa v 0,65 ml (200 µg/ml).
English: Aranesp 40 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Slovenian: Aranesp 40 mikrogramov raztopina za injiciranje v viali Ena viala vsebuje 3,79 mg natrija.
English: Aranesp 500 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 500 micrograms of darbepoetin alfa in 1 mL (500 mcg/mL).
Slovenian: Aranesp 500 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 500 mikrogramov darbepoetina alfa v 1 ml (500 µg/ml).
English: Aranesp 40 micrograms solution for injection in vial 1 mL solution for injection (40 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Slovenian: Aranesp 40 mikrogramov raztopina za injiciranje v viali 1 ml raztopine za injiciranje (40 µg/ml darbepoetina alfa) v viali iz stekla tipa 1 z elastomernim zamaškom, plastificirani s fluoropolimerom, in z aluminijasto zaporo in snemno zaporko proti prahu.
English: INFORMATION IN BRAILLE Aranesp 60 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 60 peresnik
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/102 1 pack
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/102 - pakiranje po 1
English: EU/1/01/185/062 4 pack
Slovenian: EU/1/01/185/062 - pakiranje po 4
English: Aranesp 50 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 50 micrograms of darbepoetin alfa in 0.5 mL (100 mcg/mL).
Slovenian: Aranesp 50 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 50 mikrogramov darbepoetina alfa v 0,5 ml (100 µg/ml).
English: Aranesp 500 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 500 micrograms of darbepoetin alfa in 1 mL (500 mcg/mL).
Slovenian: Aranesp 500 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku En napolnjeni injekcijski peresnik vsebuje 500 mikrogramov darbepoetina alfa v 1 ml (500 µg/ml).
English: INFORMATION IN BRAILLE Aranesp 150 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 150 peresnik
English: Aranesp 60 micrograms solution for injection in vial 1 mL solution for injection (60 mcg/mL darbepoetin alfa) in a type 1 glass vial with fluoropolymer laminated elastomeric stopper and an aluminium seal with flip-off dust cover.
Slovenian: Aranesp 60 mikrogramov raztopina za injiciranje v viali 1 ml raztopine za injiciranje (60 µg/ml darbepoetina alfa) v viali iz stekla tipa 1 z elastomernim zamaškom, plastificirani s fluoropolimerom, in z aluminijasto zaporo in snemno zaporko proti prahu.
English: INFORMATION IN BRAILLE Aranesp 40 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 40 peresnik
English: EU/1/01/185/057 - 4 pack
Slovenian: EU/1/01/185/057 - pakiranje po 4
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/043
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/043
English: Aranesp 80 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.52 mg of sodium in 0.4 mL.
Slovenian: Aranesp 80 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1,52 mg natrija v 0,4 ml.
English: Aranesp 60 micrograms solution for injection in vial Each vial contains 3.79 mg of sodium.
Slovenian: Aranesp 60 mikrogramov raztopina za injiciranje v viali Ena viala vsebuje 3,79 mg natrija.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/108 1 pack
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/108 - pakiranje po 1
English: EU/1/01/185/061 4 pack
Slovenian: EU/1/01/185/061 - pakiranje po 4
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/042
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/042
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/033
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/033
English: EU/1/01/185/101 4 pack
Slovenian: EU/1/01/185/101 - pakiranje po 4
English: Aranesp 10 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 10 micrograms of darbepoetin alfa in 0.4 mL (25 mcg/mL).
Slovenian: Aranesp 10 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 10 mikrogramov darbepoetina alfa v 0,4 ml (25 µg/ml).
English: INFORMATION IN BRAILLE Aranesp 100 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 100 peresnik
English: EU/1/01/185/068 - 4 pack
Slovenian: EU/1/01/185/068 - pakiranje po 4
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/039
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/039
English: INFORMATION IN BRAILLE Aranesp 50 syringe
Slovenian: PODATKI V BRAILLOVI PISAVI Aranesp 50 peresnik
English: Aranesp 60 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 1.14 mg of sodium in 0.3 mL.
Slovenian: Aranesp 60 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1,14 mg natrija v 0,3 ml.
English: Aranesp 50 micrograms solution for injection pre-filled pen EU/1/01/185/050 - 1 pack
Slovenian: Aranesp 50 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/01/185/050 - pakiranje po 1
English: Aranesp 300 micrograms solution for injection in pre-filled pen Each pre-filled pen contains 2.27 mg of sodium in 0.6 mL.
Slovenian: Aranesp 300 mikrogramov raztopina za injiciranje v napolnjenem injekcijskem peresniku En napolnjeni injekcijski peresnik vsebuje 2,27 mg natrija v 0,6 ml.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/038
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/038
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each 0.65 mL pre-filled syringe contains 130 micrograms darbepoetin alfa (200 micrograms/mL).
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN En 0,65-ml napolnjen injekcijski peresnik vsebuje 130 mikrogramov darbepoetina alfa (200 mikrogramov/ml).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/106 1 pack
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/106 - pakiranje po 1
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/072 1 pack
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/072 - pakiranje po 1
English: MARKETING AUTHORISATION NUMBER(S) EU/1/01/185/036
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/01/185/036
English: Aranesp 300 micrograms solution for injection in pre-filled syringe Each pre-filled syringe contains 300 micrograms of darbepoetin alfa in 0.6 mL (500 mcg/mL).
Slovenian: Aranesp 300 mikrogramov raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 300 mikrogramov darbepoetina alfa v 0,6 ml (500 µg/ml).
English: How to store Aranesp
Slovenian: Shranjevanje zdravila Aranesp